| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks
1 company
Neylan John F. serves as a See Remarks at ELTX. Across recent SEC filings that breaks down to 0 buys and 10 sells. Those positions are worth an estimated $92K at current prices.
Historically, Neylan John F.'s trades have earned a strong insider score of 95/100 across 10 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +86.2%.
The biggest single holding is ELTX (~$92K) as See Remarks. The recent filings there lean toward selling, a net 3,779 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 20, 2021 | ELTX Elicio Therapeutics, Inc. | See Remarks | Sell | 358 | $2.62 | $938.00 | -1.0% | -17.6% | -68.1% | |
| Nov 18, 2021 | ELTX Elicio Therapeutics, Inc. | See Remarks | Sell | 374 | $4.13 | $1,544.62 | -1.0% | -47.8% | -79.2% | |
| Oct 18, 2021 | ELTX Elicio Therapeutics, Inc. | See Remarks | Sell | 373 | $8.62 | $3,215.26 | -1.0% | -74.0% | -87.4% | |
| Sep 20, 2021 | ELTX Elicio Therapeutics, Inc. | See Remarks | Sell | 376 | $10.07 | $3,786.32 | -1.0% | -73.5% | -89.7% | |
| Aug 18, 2021 | ELTX Elicio Therapeutics, Inc. | See Remarks | Sell | 381 | $9.03 | $3,440.43 | -1.0% | -54.6% | -89.0% | |
| Jul 21, 2021 | ELTX Elicio Therapeutics, Inc. | See Remarks | Sell | 365 | $10.98 | $4,007.70 | -1.0% | -25.2% | -90.8% | |
| Jun 18, 2021 | ELTX Elicio Therapeutics, Inc. | See Remarks | Sell | 366 | $13.20 | $4,831.20 | -1.0% | -19.4% | -89.9% | |
| May 18, 2021 | ELTX Elicio Therapeutics, Inc. | See Remarks | Sell | 363 | $13.91 | $5,049.33 | -1.0% | -28.0% | -92.3% | |
| Apr 19, 2021 | ELTX Elicio Therapeutics, Inc. | See Remarks | Sell | 381 | $13.55 | $5,162.55 | -1.0% | -20.9% | -87.5% | |
| Mar 17, 2021 | ELTX Elicio Therapeutics, Inc. | See Remarks | Sell | 442 | $19.13 | $8,455.46 | -1.1% | -30.8% | -88.3% |